Quantifying the influence of polymer coatings on the serum albumin corona formation around silver and gold nanoparticles
Source abstract
Abstract
When nanoparticles (NPs) come into contact with biological fluids, proteins, and other biomolecules interact with their surface. Upon exposure to biological fluids a layer of proteins adsorbs onto their surface, the so-called protein corona, and interactions of biological systems with NPs are therefore mediated by this corona. Here, interactions of serum albumin with silver and gold NPs were quantitatively investigated using circular dichroism spectroscopy. Moreover, surface enhanced Raman spectroscopy was used for further elucidation of protein binding to silver surfaces. The decisive role of poly(vinylpyrrolidone), coatings on the protein adsorption was quantitatively described for the first time and the influential role of the polymer coatings is discussed. Research in nanotoxicology may benefit from such molecular scale data as well as scientific approaches seeking to improve nanomedical applications by using a wide range of polymer surface coatings to optimize biological transport and medical action of NPs.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Gold and Silver Nanoparticles Synthesis and Applications · Nanoparticles: synthesis and applications · Protein Interaction Studies and Fluorescence Analysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Abbas K, Cydzik I, Del Torchio R, Farina M, Forti E, Gibson N, Holzwarth U, Simonelli F, Kreyling WG (2010) Radiolabelling of TiO2 nanoparticles for radiotracer studies. J Nanopart Res 12:2435–244310.1007/s11051-009-9806-8 ↗
2. Aggarwal P, Hall JB, McLeland CB, Dobrovolskaia MA, McNeil SE (2009) Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv Drug Delivery Rev 61:428–43710.1016/j.addr.2009.03.009 ↗
3. Aubin-Tam M-E, Hamad-Schifferli K (2005) Gold nanoparticle-cytochrome c complexes: the effect of nanoparticle ligand charge on protein structure. Langmuir 21:12080–1208410.1021/la052102e ↗
4. Bailon P, Won CY (2009) PEG-modified biopharmaceuticals. Expert Opin Drug Del 6:1–1610.1517/17425240802650568 ↗
5. Boisselier E, Astruc D (2009) Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity. Chem Soc Rev 38:1759–178210.1039/b806051g ↗
6. Cedervall T, Lynch I, Lindman S, Berggård T, Thulin E, Nilsson H, Dawson KA, Linse S (2007) Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc Natl Acad Sci USA 104:2050–205510.1073/pnas.0608582104 ↗
7. Cometto FP, Paredes-Olivera P, Macagno VA, Patrito EM (2005) Density functional theory study of the adsorption of alkanethiols on Cu(111), Ag(111), and Au(111) in the low and high coverage regimes. J Phys Chem B 109:21737–2174810.1021/jp053273v ↗
8. De Paoli Lacerda SH, Park JJ, Meuse C, Pristinski D, Becker ML, Karim A, Douglas JFD (2010) Interaction of gold nanoparticles with common human blood proteins. ACS Nano 4:365–37910.1021/nn9011187 ↗
9. Des Rieux A, Fievez V, Garinot M, Schneider Y-J, Préat V (2006) Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach. J Control Release 116:1–2710.1016/j.jconrel.2006.08.013 ↗
10. Dutta D, Sundaram SK, Teeguarden JG, Riley BJ, Fifield LS, Jacobs JM, Addleman SR, Kaysen GA, Moudgil BM, Weber TJ (2007) Adsorbed proteins influence the biological activity and molecular targeting of nanomaterials. Toxicol Sci 100:303–31510.1093/toxsci/kfm217 ↗
11. Fass D (2012) Disulfide bonding in protein biophysics. Annu Rev Biophys 41:63–7910.1146/annurev-biophys-050511-102321 ↗
12. Ferrari M (2005) Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer 5:161–17110.1038/nrc1566 ↗
13. Galindo-Rodriguez SA, Allemann E, Fessi H, Doelker E (2005) Polymeric nanoparticles for oral delivery of drugs and vaccines: a critical evaluation of in vivo studies. Crit Rev Ther Drug Carr Syst 22:419–46410.1615/CritRevTherDrugCarrierSyst.v22.i5.10 ↗
14. Gan ZH, Yu D, Zhong Z, Liang Q, Jing X (1999) Enzymatic degradation of poly(ε-caprolactone)/poly(dl-lactide) blends in phosphate buffer solution. Polymer 40:2859–286210.1016/S0032-3861(98)00549-7 ↗
15. Garrido C, Aliaga AE, Gomez-Jeria JS, Clavijo RE, Campos-Vallette MM, Sanchez-Cortes S (2010) Adsorption of oligopeptides on silver nanoparticles: surface-enhanced Raman scattering and theoretical studies. J Raman Spectrosc 41:1149–115510.1002/jrs.2583 ↗
16. Gebauer JS, Treuel L (2011) Influence of individual ionic components on the agglomeration kinetics of silver nanoparticles. J Colloid Interface Sci 354:546–55410.1016/j.jcis.2010.11.016 ↗
17. Gebauer JS, Malissek M, Simon S, Knauer SK, Maskos M, Stauber RH, Peukert W, Treuel L (2012) Impact of the nanoparticle–protein corona on colloidal stability and protein structure. Langmuir 28:9673–967910.1021/la301104a ↗
18. Geiser M, Rothen-Rutishauser B, Kapp N, Schürch S, Kreyling WG, Schulz H, Semmler M, Im Hof V, Heyder J, Gehr P (2005) Ultrafine particles cross cellular membranes by nonphagocytic mechanisms in lungs and in cultured cells. Environ Health Perspect 113:1555–156010.1289/ehp.8006 ↗
19. Gessner A, Waicz R, Lieske A, Paulke B, Mäder K, Müller RH (2000) Nanoparticles with decreasing surface hydrophobicities: influence on plasma protein adsorption. Int J Pharmaceut 196:245–24910.1016/S0378-5173(99)00432-9 ↗
20. Ghosh P, Han G, De M, Kim CK, Rotello VM (2008) Gold nanoparticles in delivery applications. Adv Drug Deliv Rev 60:1307–131510.1016/j.addr.2008.03.016 ↗
21. Goodman CM, McCusker CD, Yilmaz T, Rotello VM (2004) Toxicity of gold nanoparticles functionalized with cationic and anionic side chains. Bioconjug Chem 15:897–90010.1021/bc049951i ↗
22. Gref R, Lück M, Quellec P, Marchand M, Dellacherie E, Harnisch S, Blunk T, Müller RH (2000) ‘Stealth’ corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. Colloid Surface B 18:301–301310.1016/S0927-7765(99)00156-3 ↗
23. Greulich C, Kittler S, Epple M, Muhr G, Köller M (2009) Studies on the biocompatibility and the interaction of silver nanoparticles with human mesenchymal stem cells (hMSCs). Langenbecks Arch Surg 394:495–50210.1007/s00423-009-0472-1 ↗
24. Hamman JH, Enslin GM, Kotzé AF (2005) Oral delivery of peptide drugs: barriers and developments. BioDrugs 19:165–17710.2165/00063030-200519030-00003 ↗
25. Han G, Chari NS, Verma A, Hong R, Martin CT, Rotello VM (2005) Controlled recovery of the transcription of nanoparticle-bound DNA by intracellular concentrations of glutathione. Bioconjugate Chem 16:1356–135910.1021/bc050173j ↗
26. Harris JM, Martin NE, Modi M (2001) Pegylation: a novel process for modifying pharmacokinetics. Clin Pharmacokinet 40:539–55110.2165/00003088-200140070-00005 ↗
27. He XM, Carter DC (1992) Atomic structure and chemistry of human serum albumin. Nature 358:209–21410.1038/358209a0 ↗
28. Hellstrand E, Lynch I, Andersson A, Drakenberg T, Dahlbäck B, Dawson KA, Linse S, Cedervall T (2009) Complete high-density lipoproteins in nanoparticle corona. FEBS J 276:3372–338110.1111/j.1742-4658.2009.07062.x ↗
29. Hogg PJ (2003) Disulfide bonds as switches for protein function. Trends Biochem Sci 28:210–21410.1016/S0968-0004(03)00057-4 ↗
30. Huang X, El-Sayed IH, Qian W, El-Sayed MA (2006) Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. J Am Chem Soc 128:2115–212010.1021/ja057254a ↗
31. Jiang X, Jiang J, Jin Y, Wang E, Dong S (2005) Effect of colloidal gold size on the conformational changes of adsorbed cytochrome c: probing by circular dichroism, UV-visible, and infrared spectroscopy. Biomacromolecules 6:46–5310.1021/bm049744l ↗
32. Jiang X, Weise S, Hafner M, Röcker C, Zhang F, Parak WJ, Nienhaus GU (2010) Quantitative analysis of the protein corona on FePt nanoparticles formed by transferrin binding. J R Soc Interface 7:S5–S1310.1098/rsif.2009.0272.focus ↗
33. Kah JCY, Wong KY, Neoh KG, Song JH, Fu JWP, Mhaisalkar S, Olivo M, Sheppard CJR (2009) Critical parameters in the pegylation of gold nanoshells for biomedical applications: an in vitro macrophage study. J Drug Targeting 17:181–19310.1080/10611860802582442 ↗
34. Kim HR, Andrieux K, Delomenie C, Chacun H, Appel M, Desmaële D, Taran F, Georgin D, Couvreur P, Taverna M (2007a) Analysis of plasma protein adsorption onto PEGylated nanoparticles by complementary methods: 2-DE, CE and protein Lab-on-chip® system. Electrophoresis 28:2252–226110.1002/elps.200600694 ↗
35. Kim HR, Andrieux K, Gil S, Taverna M, Chacun H, Desmaële D, Taran F, Georgin D, Couvreur P (2007b) Translocation of poly(ethylene glycol-co-hexadecyl)cyanoacrylate nanoparticles into rat brain endothelial cells: role of apolipoproteins in receptor-mediated endocytosis. Biomacromolecules 8:793–79910.1021/bm060711a ↗
36. Kittler S, Greulich C, Diendorf J, Köller M, Epple M (2010a) Toxicity of silver nanoparticles increases during storage because of slow dissolution under release of silver ions. Chem Mater 22:4548–455410.1021/cm100023p ↗
37. Kittler S, Greulich C, Gebauer JS, Diendorf J, Treuel L, Ruiz L, Gonzalez-Calbet JM, Vallet-Regi M, Zellner R, Köller M, Epple M (2010b) The influence of proteins on the dispersability and cell-biological activity of silver nanoparticles. J Mater Chem 20:512–51810.1039/B914875B ↗
38. Klein J (2007) Probing the interactions of proteins and nanoparticles. Proc Natl Acad Sci USA 104:2029–203010.1073/pnas.0611610104 ↗
39. Kostarelos K, Bianco A, Prato M (2009) Promises, facts and challenges for carbon nanotubes in imaging and therapeutics. Nat Nanotechnol 4:627–63310.1038/nnano.2009.241 ↗
40. Kreyling WG, Semmler M, Moller W (2004) Dosimetry and toxicology of ultrafine particles. J Aerosol Med 17:140–15210.1089/0894268041457147 ↗
41. Leroueil-Le Verger M, Fluckiger L, Kim YI, Hoffman M, Maincent P (1998) Preparation and characterization of nanoparticles containing an antihypertensive agent. Eur J Pharm Biopharm 46:137–14310.1016/S0939-6411(98)00015-0 ↗
42. Li Y, He W, Tian J, Tang J, Hu Z, Chen X (2005) The effect of Berberine on the secondary structure of human serum albumin. J Mol Struct 743:79–8410.1016/j.molstruc.2005.02.032 ↗
43. Li D, Teoh WY, Selomulya C, Woodward RC, Amal R, Rosche B (2006) Flame-sprayed superparamagnetic bare and silica-coated maghemite nanoparticles: synthesis, characterization, and protein adsorption-desorption. Chem Mater 18:6403–641310.1021/cm061861v ↗
44. Linse S, Cabaleiro-Lago C, Xue W-F, Lynch I, Lindman S, Thulin E, Radford SE, Dawson KA (2007) Nucleation of protein fibrillation by nanoparticles. Proc Natl Acad Sci USA 104:8691–869610.1073/pnas.0701250104 ↗
45. Lipka J, Semmler-Behnke M, Sperling RA, Wenk A, Takenaka S, Schleh C, Kissel T, Parak WJ, Kreyling WG (2010) Biodistribution of PEG-modified gold nanoparticles following intratracheal instillation and intravenous injection. Biomaterials 31:6574–658110.1016/j.biomaterials.2010.05.009 ↗
46. Liu Z, Wu G (2006) The electro-oxidative activity of cysteine on the Au electrode as evidenced by surface enhanced Raman scattering. Spectrochim Acta A 64:251–25410.1016/j.saa.2005.07.015 ↗
47. Lu ZX, Cui T, Shi QL (1987) Application of circular dichroism and optical rotatory dispersion in molecular biology. Science press, Beijing
48. Lundqvist M, Stigler J, Elia G, Lynch I, Cedervall T, Dawson KA (2008) Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci USA 105:14265–1427010.1073/pnas.0805135105 ↗
49. Lynch I (2006) Are there generic mechanisms governing interactions between nanoparticles and cells? Epitope mapping the outer layer of the protein-material interface. Phys A 373:511–52010.1016/j.physa.2006.06.008 ↗
50. Lynch I, Dawson KA, Linse S (2006) Detecting cryptic epitopes created by nanoparticles. Sci STKE 2006:1410.1126/stke.3272006pe14 ↗
51. Maffre P, Nienhaus K, Amin F, Parak WJ, Nienhaus GU (2011) Characterization of protein adsorption onto FePt nanoparticles using dual-focus fluorescence correlation spectroscopy. Beilstein J Nanotechnol 2:374–38337410.3762/bjnano.2.43 ↗
52. Mahl D, Greulich C, Meyer-Zaika W, Köller M, Epple M (2010) Gold nanoparticles: dispersability in biological media and cell-biological effect. J Mater Chem 20:6176–618110.1039/c0jm01071e ↗
53. Mahl D, Diendorf J, Meyer-Zaika W, Epple M (2011) Possibilities and limitations of different analytical methods for the size determination of a bimodal dispersion of metallic nanoparticles. Colloid Surface A 377:386–39210.1016/j.colsurfa.2011.01.031 ↗
54. Marambio-Jones C, Hoek EMV (2010) A review of the antibacterial effects of silver nanomaterials and potential implications for human health and the environment. J Nanopart Res 12:1531–155110.1007/s11051-010-9900-y ↗
55. Martínez-Castañón G, Niño-Martínez N, Martínez-Gutierrez F, Martínez-Mendoza J, Ruiz F (2008) Synthesis and antibacterial activity of silver nanoparticles with different sizes. J Nanopart Res 10:1343–134810.1007/s11051-008-9428-6 ↗
56. Maynard AD, Aitken RJ, Butz T, Colvin V, Donaldson K, Oberdörster G, Philbert MA, Ryan J, Seaton A, Stone V, Tinkle SS, Tran L, Walker NJ, Warheit DB (2006) Safe handling of nanotechnology. Nature 444:267–26910.1038/444267a ↗
57. Medintz IL, Konnert JH, Clapp AR, Stanish I, Twigg ME, Mattoussi H, Mauro JM, Deschamps JR (2004) A fluorescence resonance energy transfer-derived structure of a quantum dot-protein bioconjugate nanoassembly. Proc Natl Acad Sci USA 101:9612–961710.1073/pnas.0403343101 ↗
58. Monopoli MP, Baldelli Bombelli F, Dawson KA (2011a) Nanobiotechnology: nanoparticle coronas take shape. Nat Nanotechnol 6:11–1210.1038/nnano.2010.267 ↗
59. Monopoli MP, Walczyk D, Campbell A, Elia G, Lynch I, Bombelli FB, Dawson KA (2011b) Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. J Am Chem Soc 133:2525–253410.1021/ja107583h ↗
60. Nel A, Xia T, Mädler L, Li N (2006) Toxic potential of materials at the nanolevel. Science 311:622–62710.1126/science.1114397 ↗
61. Nel AE, Mädler L, Velegol D, Xia T, Hoek EMV, Somasundaran P, Klaessig F, Castranova V, Thompson M (2009) Understanding biophysicochemical interactions at the nano-bio interface. Nat Mater 8:543–55710.1038/nmat2442 ↗
62. Niidome T, Yamagata M, Okamoto Y, Akiyama Y, Takahashi H, Kawano T, Y. K, Niidome Y (2006) PEG-modified gold nanorods with a stealth character for in vivo applications. J Control Release 114:343–34710.1016/j.jconrel.2006.06.017 ↗
63. Nogami N, Sugeta H, Miyazawa T (1975) C–S stretching vibrations and molecular conformations of isobutyl methyl sulfide and related alkyl sulfides. Bull Chem Soc Jpn 48:2417–242010.1246/bcsj.48.2417 ↗
64. Oberdörster G, Oberdörster E, Oberdörster J (2005) Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113:823–83910.1289/ehp.7339 ↗
65. Oberdörster G, Maynard A, Donaldson K, Castranova V, Fitzpatrick J, Ausman K, Carter J, Karn B, Kreyling WG, Lai D, Olin S, Monteiro-Riviere N, Warheit D, Yang H (2007) Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol 2:1–35
66. Pal S, Tak YK, Song JM (2007) Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the Gram-negative bacterium escherichia coli. Appl Environ Microbiol 73:1712–172010.1128/AEM.02218-06 ↗
67. Peng ZG, Hidajat K, Uddin MS (2004) Adsorption and desorption of lysozyme on nano-sized magnetic particles and its conformational changes. Colloid Surf B 35:169–17410.1016/j.colsurfb.2004.03.010 ↗
68. Perracchia M, Harnisch S, Pinto-Alphandary H, Gulik A, Dedieu J, Desmaële D, d′Angelo J, Müller RH, Couvreur P (1999) Visualization of in vitro protein-rejecting properties of PEGylated stealth® polycyanoacrylate nanoparticles. Biomaterials 20:1269–127510.1016/S0142-9612(99)00021-6 ↗
69. Podstawka E, Ozaki Y, Proniewicz LM (2004) Adsorption of S–S containing proteins on a colloidal silver surface studied by surface-enhanced Raman spectroscopy. Appl Spectrosc 58:1147–115610.1366/0003702042336073 ↗
70. Poland CA, Duffin R, Kinloch I, Maynard A, Wallace WAH, Seaton A, Stone V, Brown S, MacNee W, Donaldson K (2008) Carbon nanotubes introduced into the abdominal cavity ofmice show asbestoslike pathogenicity in a pilot study. Nature 3:423–428
71. Roach P, Farrar D, Perry CC (2006) Surface tailoring for controlled protein adsorption: effect of topography at the nanometer scale and chemistry. J Am Chem Soc 128:3939–394510.1021/ja056278e ↗
72. Röcker C, Pötzl M, Zhang F, Parak WJ, Nienhaus GU (2009) A quantitative fluorescence study of protein monolayer formation on colloidal nanoparticles. Nat Nanotechnol 4:577–58010.1038/nnano.2009.195 ↗
73. Rodriguez CE, Fukuto JM, Taguchi JM, Froines J, Cho AK (2005) The interactions of 9,10-phenanthrenequinone with glyceraldehyde-3-phosphate dehydrogenase (GAPDH), a potential site for toxic actions. Chem Biol Interact 155:97–11010.1016/j.cbi.2005.05.002 ↗
74. Rostek A, Mahl D, Epple M (2011) Chemical composition of surface-functionalized gold nanoparticles. J Nanopart Res 13:4809–481410.1007/s11051-011-0456-2 ↗
75. Rothen-Rutishauser B, Kiama SG, Gehr P (2005) A three-dimensional cellular model of the human respiratory tract to study the interaction with particles. Am J Respir Cell Mol Biol 32:281–28910.1165/rcmb.2004-0187OC ↗
76. Schlücker S, Liang C, Strehle KR, DiGiovanna JJ, Kraemer KH, Levin IW (2006) Conformational differences in protein disulfide linkages between normal hair and hair from subjects with trichothiodystrophy: a quantitative analysis by Raman microspectroscopy. Biopolymers 82:615–62210.1002/bip.20515 ↗
77. Seil J, Webster T (2012) Antimicrobial applications of nanotechnology: methods and literature. Int J Nanomed 7:2767–2781
78. Semmler-Behnke M, Takenaka S, Fertsch S, Wenk A, Seitz J, Mayer P, Oberdörster G, Kreyling WG (2007) Efficient elimination of inhaled nanoparticles from the alveolar region: evidence for interstitial uptake and subsequent reentrainment onto airways epithelium. Environ Health Perspect 115:728–73310.1289/ehp.9685 ↗
79. Shang L, Wang Y, Jiang J, Dong S (2007) pH-dependent protein conformational changes in albumin: gold nanoparticle bioconjugates: a spectroscopic study. Langmuir 23:2714–272110.1021/la062064e ↗
80. Shang L, Dong SJ, Nienhaus GU (2011a) Ultra-small fluorescent metal nanoclusters: synthesis and biological applications. Nano Today 6:401–41810.1016/j.nantod.2011.06.004 ↗
81. Shang L, Dörlich RM, Brandholt S, Schneider R, Trouillet V, Bruns M, Gerthsen D, Nienhaus GU (2011b) Facile preparation of water-soluble fluorescent gold nanoclusters for cellular imaging applications. Nanoscale 3:2009–201410.1039/c0nr00947d ↗
82. Shang L, Brandholt S, Stockmar F, Trouillet V, Bruns M, Nienhaus GU (2012) Effect of protein adsorption on the fluorescence of ultrasmall gold nanoclusters. Small 8:661–66510.1002/smll.201101353 ↗
83. Sharma B, Frontiera RR, Henry A-I, Ringe E, Van Duyne RP (2012) SERS: materials, applications, and the future. Mater Today 15:16–2510.1016/S1369-7021(12)70017-2 ↗
84. Stewart S, Fredericks PM (1999) Surface-enhanced Raman spectroscopy of amino acids adsorbed on an electrochemically prepared silver surface. Spectrochim Acta A 55:1641–166010.1016/S1386-1425(98)00294-7 ↗
85. Sugeta H, Go A, Miyazawa T (1972) S–S and C–S streching vibrations and molecular conformations of dialkyl disulfides and cystine. Chem Lett 1:83–8610.1246/cl.1972.83 ↗
86. Tasis D, Tagmatarchis N, Bianco A, Prato M (2006) Chemistry of carbon nanotubes. Chem Rev 106:1105–113610.1021/cr050569o ↗
87. Tenzer S, Docter D, Rosfa S, Wlodarski A, Kuharev J, Rekik A, Knauer SK, Bantz C, Nawroth T, Bier C, Sirirattanapan J, Mann W, Treuel L, Zellner R, Maskos M, Schild H, Stauber RH (2011) Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis. ACS Nano 5:7155–716710.1021/nn201950e ↗
88. Thode K, Lück M, Semmler W, Müller RH, Kresse M (1997) Determination of plasma protein adsorption on magnetic iron oxides: sample preparation. Pharm Res 14:905–91010.1023/A:1012104017761 ↗
89. Treuel L, Malissek M (2012) Interaction of nanoparticles with proteins-determination of equilibrium constants (accepted). In: Weissig V (ed) Cellular and sub-cellular nanotechnology: methods and protocols. Springer, New York
90. Treuel L, Nienhaus G (2012) Toward a molecular understanding of nanoparticle–protein interactions. Biophys Rev 4:137–14710.1007/s12551-012-0072-0 ↗
91. Treuel L, Malissek M, Gebauer JS, Zellner R (2010) The influence of surface composition of nanoparticles on their interactions with serum albumin. ChemPhysChem 11:3093–309910.1002/cphc.201000174 ↗
92. Turkevich J, Stevenson PC, Hillier J (1951) A study of the nucleation and growth processes in the synthesis of colloidal gold. Faraday Discuss 11:55–7510.1039/df9511100055 ↗
93. Verma A, Rotello VM (2005) Surface recognition of biomacromolecules using nanoparticle receptors. Chem Commun 303–31210.1039/b410889b ↗
94. Vertegel AA, Siegel RW, Dordick JS (2004) Silica nanoparticle size influences the structure and enzymatic activity of adsorbed lysozyme. Langmuir 20:6800–680710.1021/la0497200 ↗
95. Villalonga R, Cao R, Gragoso A (2007) Supramolecular chemistry of cyclodextrins in enzyme technology. Chem Rev 107:3088–311610.1021/cr050253g ↗
96. Wang Y, Sun HF, Wang HF, Liu YF (2001) In vitro interaction of nicotine and hemoglobin under liver cell metabolizing condition. Chinese Chem Lett 12:449–452
97. Wang H, Qiao X, Chen J, Ding S (2005) Preparation of silver nanoparticles by chemical reduction method. Colloid Surf A 256:111–11510.1016/j.colsurfa.2004.12.058 ↗
98. Watanabe T, Maeda H (1989) Adsorption-controlled redox activity. Surface-enhanced Raman investigation of cystine versus cysteine on silver electrodes. J Phys Chem 93:3258–326010.1021/j100345a075 ↗
99. Wedemeyer WJ, Welker E, Narayan M, Scheraga HA (2000) Disulfide bonds and protein folding. Biochemistry 39:703210.1021/bi005111p ↗
100. Xiao Q, Huang S, Liu Y, Tian F, Zhu J (2009) Thermodynamics, conformation and active sites of the binding of Zn–Nd hetero-bimetallic schiff base to bovine serum albumin. J Fluoresc 19:317–32610.1007/s10895-008-0418-y ↗